Evidence map›Paper›PMID 30271985›Full record

ArticleCommunications biology2018

A universal bioluminescence resonance energy transfer sensor design enables high-sensitivity screening of GPCR activation dynamics.

Hannes Schihada, Sylvie Vandenabeele, Ulrike Zabel, Monika Frank, Martin J Lohse, Isabella Maiellaro

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Bioluminescent Systems for Theranostic Applications.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. How Carvedilol activates βNature communications · 2022
    Article
  13. Article
  14. Review
  15. Functional modulation of PTH1R activation and signaling by RAMP2.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. A NanoBRET-Based HInternational journal of molecular sciences · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hannes SchihadaInstitute of Pharmacology and Toxicology and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
Sylvie VandenabeeleInstitute of Pharmacology and Toxicology and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
Ulrike ZabelInstitute of Pharmacology and Toxicology and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
Monika FrankInstitute of Pharmacology and Toxicology and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany.
Martin J LohseInstitute of Pharmacology and Toxicology and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany. lohse@toxi.uni-wuerzburg.de.
Isabella MaiellaroInstitute of Pharmacology and Toxicology and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany. isabella.maiellaro@toxi.uni-wuerzburg.de.
University of Würzburg · DEMax Delbrück Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G-protein-coupled receptors (GPCRs) represent one of the most important classes of drug targets. The discovery of new GCPR therapeutics would greatly benefit from the development of a generalizable high-throughput assay to directly monitor their activation or de-activation. Here we screened a variety of labels inserted into the third intracellular loop and the C-terminus of the α

Identifiers

PMID30271985
PMCPMC6123785
OpenAlexW2886169682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.